Determinants of final infarct size and incidence of aborted infarction in patients treated with primary coronary intervention and adjunctive abciximab therapy

NuklearMedizin

Volumn 47, Issue 1, 2008, Pages 56-61

  Sciagrà, Roberto ^a   Parodi, G ^b   Sotgia, B ^a   Antoniucci, D ^b   Pupi, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute myocardial infarction; Gated single photon emission computed tomography; Myocardial perfusion scintigraphy; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION;

AGED; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STENTS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 39449118509     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0117     Document Type: Article

References (31)

1. Ababneh AA, Sciacca RR, Kim B et al. Normal limits for left ventricular ejection fraction and volumes estimated with gated myocardial perfusion imaging in patients with normal exercise test results: influence of tracer, gender, and acquisition camera. J Nucl Cardiol 2000; 7: 661-668.
2. Antoniucci D, Rodriguez A, Hempel A et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 2003; 42: 1879-1885.
3. Chua T, Kiat H, Germano G et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23: 1107-1114.
4. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36: 952-955.
5. Dowdy L, Wagner GS, Birnbaum Y et al. Aborted infarction: the ultimate myocardial salvage. Am Heart J 2004; 147: 390-394.
6. Germano G, Kiat H, Kavanagh PB et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
7. Gibbons RJ, Christian TF, Hopfenspringer M et al. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trial of acute interventions. J Am Coll Cardiol 1994; 24: 616-623.
8. Gibbons RJ, Valeti US, Araoz PA et al. The quantification of infarct size. J Am Coll Cardiol 2004; 44: 1533-1542.
9. Kroll D, Farah W, McKendall GR et al. Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction. Am J Cardiol 2001; 87: 381-386.
10. Lamfers EJ, Hooghoudt TE, Uppelschoten A et al. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999; 84: 928-930.
11. Lamfers EJ, Schut A, Hertzberger DP et al. Pre-hospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am Heart J 2004; 147: 509-515.
12. 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction. Eur J Nucl Med Mol Imaging 2004; 31: 1378-1385.
13. Leoncini M, Marcucci G, Sciagrà R et al. Nitrate-enhanced gated Tc-99m sestamibi SPECT for evaluating regional wall motion at baseline and during low dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison with two-dimensional echocardiography. J Nucl Cardiol 2000; 7: 426-431.
14. McLaughlin MG, Stone GW, Aymong E et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CAD-ILLAC) trial. J Am Coll Cardiol 2004; 44: 1215-1223.
15. Mehilli J, Ndrepepa G, Kastrati A et al. Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol 2005; 45: 828-831.
16. Ndrepepa G, Kastrati A, Schwaiger M et al. Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med 2005; 46: 1782-1788.
17. O'Connor MK, Hammel T, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 1990; 17: 69-76.
18. Rentrop KP, Cohen M, Blanke H et al. Changes in collateral filling after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-592
19. Santoro GM, Antoniucci D, Valenti R et al. Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction. Am J Cardiol 1997; 80: 685-689.
20. Schomig A, Ndrepepa G, Mehilli J et al. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 2003; 108: 1084-1088.
21. 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 2004; 31: 969-974.
22. Sciagrà R, Leoncini M. Gated single-photon emission computed tomography. The present-day "one-stop-shop" for cardiac imaging. Q J Nucl Med Mol Imaging 2005; 49: 19-29.
23. Sharir T, Bacher-Stier C, Dhar S et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol 2000; 86: 1171-1175.
24. Tadamura E, Kudoh T, Motooka M et al. Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging. J Am Coll Cardiol 1999; 33: 991-997.
25. Taher T, Fu Y, Wagner GS et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 2004; 44: 38-43.
26. The TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1985; 312: 932-936.
27. Thiele H, Kappl MJ, Linke A et al. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J 2007 Jun 6; Epub ahead of print.
28. Topol EJ, Neumann FJ, Montalescot G. A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 2003; 42: 1886-1889.
29. Vatner SF, Baig H, Manders WT et al. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1978; 61: 1048-1056.
30. Weaver WD, Cerqueira M, Hallstrom AP et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270: 1211-1216.
31. Wu E, Judd RM, Vargas JD et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-8.